Experimental Obesity Drug Survodutide Did Not Raise Heart Attack or Stroke Risk in 5,530-Patient Safety Trial
A large trial found that experimental obesity drug survodutide did not increase major cardiovascular risks, but it has not been shown to protect the heart and caused frequent digestive side effects.
Medical Daily ·